Quality Manager Interview Questions for Medical Devices: Leadership and Case Studies

Interviews for quality manager, head of quality and QA lead roles go beyond technical knowledge. Panels want to see judgement under pressure, the ability to influence senior colleagues and a clear sense of when to say no. This guide has 8 model questions with answers and three case studies with ideal answers on shipping pressure, an unannounced FDA visit and a notified body finding.

What to prepare

Prepare three stories: a quality failure you handled, an inspection or audit you led, and a time you disagreed with a senior colleague. Know your numbers: audit results, CAPA cycle times, complaint trends. Revise ISO 13485 and MDSAP audit readiness, FDA inspections, the QMSR implementation checklist and CAPA and complaint handling.

Eight common questions with model answers

1. How do you build a risk-based quality system that is not just paperwork?

Model answer: “I start from patient risk and the regulatory requirements, then scale each process to what matters. Simple, clear procedures, records that people actually use, and metrics that drive decisions. I remove steps that add no control, and make sure high-risk areas such as design changes, sterilisation and complaints get the strongest controls. The test is whether the system helps people do the right thing, and whether it would stand up in an inspection.”

2. How do you prepare for an FDA inspection?

Model answer: “Continuous readiness rather than a rush. Regular internal audits against the QMSR, a strong CAPA and complaint process, a trained inspection team with defined roles, a front room and back room plan, and mock inspections. I make sure staff know to answer the question asked, truthfully, and to ask for clarification when unsure.”

3. Which KPIs do you report at management review?

Model answer: “Complaint trends and reportability timeliness, CAPA effectiveness and overdue actions, nonconformance and scrap rates, internal and external audit findings, supplier performance, training compliance, and change-related metrics. I look for trends and what decisions they need, not just numbers.”

4. How do you handle pressure from production or sales to ship?

Model answer: “By being clear about what is negotiable and what is not. Compliance and patient safety are not negotiable. I involve the business early, offer solutions such as expedited testing or rework, and explain risk in plain language. If the answer has to be no, I explain why and what would change it.”

5. How do you build a culture of quality?

Model answer: “Through leadership behaviour, visible follow-through and making it safe to report problems. I thank people who raise issues, close the loop on what happens next, and tie quality goals to business goals. Training is relevant to each role. When quality is treated as everyone’s job, the quality team is not the only owner.”

6. How would you approach a gap assessment for a regulatory change such as the QMSR?

Model answer: “Map the new requirements to the existing system, identify gaps by risk, assign owners and deadlines, update procedures and training, and verify through internal audit. For the QMSR, much of the work is aligning terminology and records with ISO 13485 and checking areas where FDA retained specific requirements. I report progress through management review.”

7. How do you decide whether a problem needs a field action or recall?

Model answer: “I assess the health hazard: severity and probability of harm, affected population and units, whether the problem can be detected by users, and the options for control. I involve regulatory, clinical and risk experts, document the decision and meet reporting duties, for example corrections and removals reporting in the US and field safety corrective action rules in the EU. When in doubt, I escalate early.”

8. Tell me about a mistake you made and what you learned.

Model answer (STAR): “I once approved a change without confirming a downstream validation impact (situation). A later audit found the gap (task). I opened a CAPA, assessed affected lots, revalidated and changed the change-control form to require a validation impact check (action). The same finding has not recurred, and I now ask the ‘what does this touch’ question every time (result).”

Case study 1: shipping pressure

Scenario: The CEO asks you to release a lot with an open nonconformance because a hospital customer is waiting and the deviation is described as “cosmetic”.

Ideal answer: “First, I would verify that it is truly cosmetic by reviewing the evidence and the risk file, with engineering input. If it does not affect safety, performance or labelling, I would document a disposition, such as use-as-is with a justified rationale, approved by the right people, and release. If there is any doubt, or if it affects function, I would not release. I would offer alternatives, such as rework or an expedited retest, and explain the regulatory and patient risk in business terms. The decision must be documented and traceable either way.”

Case study 2: unannounced FDA investigator

Scenario: An FDA investigator arrives at reception without notice. The site manager is away and staff are anxious.

Ideal answer: “I would ask reception to verify credentials, record the visit and call the inspection lead. The investigator is welcomed politely and taken to a designated room while the team assembles. I would activate the inspection plan: a scribe to log requests, a runner to retrieve documents, subject-matter experts called as needed, and legal or senior leadership informed. Staff answer truthfully and only what is asked, and records are provided promptly and copies tracked. I would hold a daily debrief, address any observations in real time where possible and respond to a Form 483 within fifteen business days.”

Case study 3: major nonconformity before a certificate decision

Scenario: A notified body audit raises a major nonconformity on your design change process two weeks before the certification decision.

Ideal answer: “I would take it seriously and respond within the notified body’s timeline. I would understand the finding, then carry out a root cause analysis, assess the impact on products already changed, correct the specific cases and implement a systemic corrective action, such as a revised procedure and retraining. I would give evidence, not promises, and ask the notified body what it needs to see for closure. I would also tell leadership early about the risk to the timeline, and make sure that the response is truthful and complete, because an incomplete response is likely to make matters worse.”

Mistakes to avoid

• Describing yourself as the quality “police”. Leaders enable compliance through the business.
• Giving only technical answers. Panels also look at communication and judgement.
• Claiming that audits never find anything. Show how you respond to findings.
• Not knowing your numbers.

Frequently asked questions

How technical should my answers be?

Match the audience. Executives want risk, impact and decisions. Technical panels want detail on the process. Prepare both versions.

Should I mention a time I disagreed with leadership?

Yes, if you can show you stayed professional, used evidence and reached a good outcome. It demonstrates the independence the role needs.

What to read next?

See the QA interview guide, supplier quality interview guide and career mentoring roadmap. Structured learning is available in our Advanced QMS course.

Model answers are examples; adapt them to your real experience.

Talk to the AptSkill team

Preparing for a quality leadership interview? Send us a message.